Glatiramer Acetate Injection, Solution
Product Images NDC 0378-6961

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 0378-6961). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glatiramer Acetate Structural Formula (5cd25695 8a5c 48b6 Bd73 86a48de41493 01)

FDA Label Image

Figure 1: Time To Second Exacerbation (5cd25695 8a5c 48b6 Bd73 86a48de41493 02)

This appears to be a statistical analysis report of Glatiramer Acetate, a medication used to treat multiple sclerosis. The hazard ratio is given as 0.55 which indicates a lower hazard rate in patients taking the drug compared to placebo. The table shows the percentage of patients experiencing a second exacerbation on placebo vs Glatiramer Acetate over a period of 10 days. However, some of the text is corrupted and the table format is unclear, so the information may not be entirely usable.*

FDA Label Image

Figure 2: Median Cumulative Number Of Gd-enhancing Lesions (5cd25695 8a5c 48b6 Bd73 86a48de41493 03)

FDA Label Image

Instructions For Use Figure A (Image 01)

FDA Label Image

Instructions For Use Figure B (Image 02)

FDA Label Image

Instructions For Use Figure C (Image 03)

This appears to be a set of instructions for body measurement, with specific areas to avoid and areas to measure for the abdomen, back of hips and arms, arms, and thighs. The text refers to fleshy areas and provides measurements for each area. There is also an accompanying image labeled "Figure C".*

FDA Label Image

Instructions For Use Figure D (Image 04)

FDA Label Image

Instructions For Use Figure E (Image 05)

FDA Label Image

Instructions For Use Figure F (Image 06)

FDA Label Image

Instructions For Use Figure G (Image 07)

FDA Label Image

Instructions For Use Figure H (Image 08)

FDA Label Image

Instructions For Use Figure I (Image 09)

FDA Label Image

Instructions For Use Figure J (Image 10)

FDA Label Image

Instructions For Use Figure K (Image 11)

FDA Label Image

Instructions For Use Figure L (Image 12)

FDA Label Image

Glatiramer Acetate Injection 40 mg/ml Carton Label (Image 13)

This is a prescription drug called Glatiramer Acetate. It is an injection given under the skin, and it should be refrigerated and protected from light. It is available in 40mg/mL strength, and the usual dosage is three times a week. The medication comes in pre-filled syringes with fixed needles. The package contains 12 syringes and the prescription needs to be dispensed as a unit package in a carton. The active ingredient is 40mg of Glatiramer Acetate, and the inactive ingredients are manitol and sterile water. Dosage and other important information can be found in the accompanying prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.